FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking - Abbott Laboratories (N

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.